GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC-COA-0000917/2025

Merz Pharmaceuticals LLC, Merz Therapeutics GmbH, Merz Pharma France v. Viatris Santé

Datum
2026-04-27
Kammer
Luxembourg (LU)
Verfahrensart
Appeal RoP220.1
Sprache
EN

Metadaten

Fall-IDUPC-COA-0000917-2025-d1b631fddad2
AktenzeichenUPC-COA-0000917/2025
RegisterzeichenUPC-COA-0000917/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze
_blocked_reasonchallenge_page_detected
_parsing_noticeThe server returned an interstitial/challenge page instead of the expected detail page.

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 26 January 2026 regarding a request pursuant to R. 262.2 RoP HEADNOTES - According to case-law, only R. 262A RoP allows the Court to restrict the use of confidential information by the opposing party and its representatives. A request under R. 262.2 RoP that certain information of written pleadings or evidence be kept confidential does not automatically grant provisional protection against the disclosure of information by the other party (UPC_CoA_70/2025, order of 1 August 2025, Strabag vs Swarco et al, paras 19 and 20). Furthermore, and as set out repeatedly, a decision on a request according to R. 262.2 RoP is generally not made until a reasoned request from the public under R. 262.1(b) RoP is lodged. This is because re ...